Thamil Annamalai

Health Technology

Consumer Services

Active connections

Name	Gender	Age	Linked companies	Collaboration
William Waddill	M	67	PROTAGONIST THERAPEUTICS, INC.	8 years
Ashok Bhandari	M	-	PROTAGONIST THERAPEUTICS, INC.	7 years

Connections Chart

Multi-company connection

Former connections

Name	Gender	Age	Linked companies	Collaboration
William Rieflin	M	64	XENOPORT, INC.	12 years
Vincent Angotti	M	56	XENOPORT, INC.	8 years
Gianna M. Bosko	F	54	XENOPORT, INC.	10 years
Dennis Fenton	M	72	XENOPORT, INC.	7 years
Julie Grant	F	41	PROTAGONIST THERAPEUTICS, INC.	2 years
Gregory T. Bates	M	65	XENOPORT, INC.	-
Catherine Friedman	F	63	XENOPORT, INC.	9 years
Thomas O'Neil	M	59	PROTAGONIST THERAPEUTICS, INC.	3 years
David Savello	M	78	XENOPORT, INC.	-
Paul Berns	M	57	XENOPORT, INC.	11 years
Robert W. Overell	M	69	XENOPORT, INC.	6 years
Chaitan Khosla	M	59	PROTAGONIST THERAPEUTICS, INC.	6 years
Kenneth J. Nussbacher	M	70	XENOPORT, INC.	10 years
Jeryl Hilleman	F	67	XENOPORT, INC.	14 years
Ernest Mario	M	85	XENOPORT, INC.	3 years
Per G. H. Lofberg	M	76	XENOPORT, INC.	2 years
Paul Goddard	M	74	XENOPORT, INC.	5 years
David Edgren	M	-	XENOPORT, INC.	-
Steven Bryant Porter	M	66	IntraBiotics Pharmaceuticals, Inc. IntraBiotics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology IntraBiotics, a developer of antibiotics and antifungals is focused on one drug candidate, iseganan hydrochloride oral solution, which would be used for the prevention of ventilator-associated pneumonia and to help cystic fibrosis patients fight respiratory infections.	2 years
May D. Lee	M	-	Essential Therapeutics, Inc. Essential Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Essential Therapeutics, Inc. manufactures pharmaceutical goods for viral and fungal infections	7 years
Gary D. Tollefson	M	72	XENOPORT, INC.	4 years
David J. Wustrow	M	65	XENOPORT, INC.	4 years
Richard S. Shames	M	-	PROTAGONIST THERAPEUTICS, INC.	4 years
Bryan Roberts	M	57	XENOPORT, INC.	7 years
Peter Virsik	M	-	XENOPORT, INC.	10 years
Williamson Z. Bradford	M	62	IntraBiotics Pharmaceuticals, Inc. IntraBiotics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology IntraBiotics, a developer of antibiotics and antifungals is focused on one drug candidate, iseganan hydrochloride oral solution, which would be used for the prevention of ventilator-associated pneumonia and to help cystic fibrosis patients fight respiratory infections.	3 years
Dmitri V. Lissin	M	55	XENOPORT, INC.	4 years
Lucio Tozzi	M	60	PROTAGONIST THERAPEUTICS, INC.	4 years
Gary Titus	M	64	IntraBiotics Pharmaceuticals, Inc. IntraBiotics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology IntraBiotics, a developer of antibiotics and antifungals is focused on one drug candidate, iseganan hydrochloride oral solution, which would be used for the prevention of ventilator-associated pneumonia and to help cystic fibrosis patients fight respiratory infections.	2 years
William Hodder	M	-	PROTAGONIST THERAPEUTICS, INC.	-
Daniel M. Canafax	M	71	XENOPORT, INC.	5 years
David Stamler	M	63	XENOPORT, INC.	2 years
Matt Hogan	M	64	Essential Therapeutics, Inc. Essential Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Essential Therapeutics, Inc. manufactures pharmaceutical goods for viral and fungal infections	3 years
Pierre V. Trân	M	64	XENOPORT, INC.	3 years
Thomas Woiwode	M	52	XENOPORT, INC.	2 years
Thomas R. Parr	M	70	IntraBiotics Pharmaceuticals, Inc. IntraBiotics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology IntraBiotics, a developer of antibiotics and antifungals is focused on one drug candidate, iseganan hydrochloride oral solution, which would be used for the prevention of ventilator-associated pneumonia and to help cystic fibrosis patients fight respiratory infections.	1 years
Annie Li	F	-	IntraBiotics Pharmaceuticals, Inc. IntraBiotics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology IntraBiotics, a developer of antibiotics and antifungals is focused on one drug candidate, iseganan hydrochloride oral solution, which would be used for the prevention of ventilator-associated pneumonia and to help cystic fibrosis patients fight respiratory infections.	-
Patricia A. Murphy	F	65	PROTAGONIST THERAPEUTICS, INC.	-
Richard A. Farley	M	-	XENOPORT, INC.	-
Robert A. Reed	M	63	XENOPORT, INC.	3 years
Jerry M. Buysse	M	68	Essential Therapeutics, Inc. Essential Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Essential Therapeutics, Inc. manufactures pharmaceutical goods for viral and fungal infections	7 years
Asish Xavier	M	-	PROTAGONIST THERAPEUTICS, INC.	3 years
Bill Harris	M	65	XENOPORT, INC.	15 years
Ryan Ward	M	-	XENOPORT, INC.	7 years

Statistics

Country	Connections	% of total
United States	46	100.00%

Age of Connections

Active

Past

Male

Female

Members of the board

Executives

Origin of connections